Susan retired from Mintz and her roles as Division Head of the firm’s Health Law Practice and Managing Partner of the firm’s Washington, DC office in 2023.
viewpoints
Life Sciences Newsletter — September 2021
September 1, 2021 | Article | By Adam Lenain, William Whelan, Jonathan L. Kravetz , Terri Shieh-Newton
This edition covers return-to-work challenges, insight on patenting AI innovations, FDA guidance on medical devices, transactional and IP activity in the life sciences, and recent Mintz work for life sciences clients.
Read more
Life Sciences Newsletter — Inaugural Edition
August 20, 2020 | Article | By Adam Lenain, William Whelan, Jonathan L. Kravetz , Terri Shieh-Newton
The inaugural Mintz Life Sciences Newsletter brings the latest developments in life sciences, legal insights, and industry activity straight to your inbox.
Read more
Private Equity Investment in Health Care Technology
January 22, 2020 | Video
Susan Berson explains why health care technology and artificial intelligence are of particular interest to private equity investors and why these investors are uniquely positioned to invest in technology and bring it to market.
Read more
Trump Administration Withdraws Proposed Rebate Rule
July 11, 2019 | Blog | By Theresa Carnegie
In an unexpected turn of events, the Trump administration has apparently reversed course and has withdrawn the proposed rule that would have amended the discount safe harbor under the Anti-Kickback Statute to eliminate protections for certain drug rebates paid by pharmaceutical manufacturers. “Based on careful analysis and thorough consideration, the president has decided to withdraw the rebate rule. The Trump administration is encouraged by continuing bipartisan conversations about legislation to reduce outrageous drug costs imposed on the American people, and President Trump will consider using any and all tools to ensure that prescription drug costs will continue to decline," White House Deputy Press Secretary Judd Deere said in a statement.
Read more
President Trump Delivers Much Anticipated Drug Pricing Speech
May 14, 2018 | Blog | By Theresa Carnegie, Tara E. Dwyer
On Friday, after weeks of delay, the President finally delivered his Drug Pricing Speech and released the HHS Blueprint detailing the Trump Administration's plan to lower drug prices and reduce out-of-pocket costs.
Read more
C-THRU’s Proposed Changes to Negotiated Prices – A Demonstration of the Part D Program’s Complexities and Misunderstandings
March 29, 2017 | Blog | By Tara E. Dwyer
As described in last week’s post, Senator Wyden has introduced the C-THRU Act that seeks to require public disclosure of PBM rebate amounts, establish a minimum rebate percentage that PBMs must pass on to Part D and Exchange Plan clients, and intends to change the definition and/or application of “negotiated prices” under the Part D program.
Read more
OIG Publishes Online Portfolio Highlighting its Body of Work on Drug Pricing and Reimbursement
February 21, 2017 | Blog
For several years now, the public outcry over the issue of drug pricing and reimbursement has increased in frequency and fervor. At least one government agency wants you to know that it has been listening and wants to help provide the information necessary to forge a solution.
Read more
Senate Bill Targets Part D DIR Fees
October 11, 2016 | Blog | By Tara E. Dwyer
Just last month the “Improving Transparency and Accuracy in Medicare Part D Spending Act” was introduced in the Senate to amend the Social Security Act. The bill seeks to prohibit Part D plans (and their contracted pharmacy benefit managers (PBMs)) from retroactively reducing payments to pharmacies for clean claims.
Read more
Four Days Until The Mintz/ML Strategies Pharmacy Industry Summit
May 6, 2016 | Blog | By Theresa Carnegie
Here in Washington, it seems everyone has an idea on a drug “fix”: amendments to the provisions governing Medicare reimbursement, new rebate requirements, changes to price reporting measures, revisions to the 340B Drug Discount Program, etc. Proposals are interesting, but will Congress actually do anything? If anything is actually going to pass, it has to get through the Senate.
Read more
Five Days Until The Mintz/ML Strategies Pharmacy Industry Summit
May 5, 2016 | Blog | By Theresa Carnegie
Following our first panel discussing Drug Pricing Challenges and Opportunities, the second panel, which Theresa is moderating involves a subject near and dear to the heart of many of our clients: The New Wave of Value-Based Pricing and Contracting.
Read more
News & Press
Ask A Mentor: How Can I Successfully Switch Practices?
November 9, 2021|
Mintz Advises Kindred at Home in $5.7 Billion Sale to Humana
August 23, 2021|
Law360's 2021 Health Care Editorial Advisory Board
April 7, 2021|
Mintz Attorneys and Practices Recognized by Chambers USA 2020
April 24, 2020|
TPG Invests in Behavioral Health Firm LifeStance
April 20, 2020|
Mintz Recognized by Chambers USA 2019
April 26, 2019|
Mentoring at Mintz
November 13, 2018|
Chambers USA 2018 Ranks Mintz Attorneys & Practices
May 3, 2018|
Mintz is advising a consortium of investors led by TPG Capital and Welsh, Carson, Anderson & Stowe in their acquisition of Kindred Healthcare, Inc. The definitive agreement totals approximately $4.1 billion in cash including the assumption or repayment of net debt.
Firm’s National Healthcare Practice, NY Corporate/M&A and Litigation: General Commercial Among Newest Rankings
podcasts
Health Law Diagnosed — Transactions Part 1: Regulatory Trends in Recent Health Care Transactions
March 3, 2022 | Podcast | By Xavier Hardy, Bridgette Keller, Lauren Moldawer, Cassandra Paolillo, Kate Stewart
2021 was a busy year for Mintz ’s Health Law team, as they helped clients navigate complex health care transactions.
Read more
Health Law Diagnosed — Women in Health Law: Leadership, Mentorship, and Beyond
June 17, 2021 | Podcast
In this episode of the Health Law Diagnosed podcast, Mintz’s Susan Berson discusses her career trajectory, the benefits of building a diverse and inclusive workplace, why women may be drawn to health law, and the importance of mentorship and sponsorship.
Read more
Events & Speaking
Speaker
Panelist
Apr
21
2021
Women in Law & Leadership Virtual Summit - Washington, D.C.
The Women in Law Summit Series
Virtual Event
Moderator
Speaker
Sep
23
2020
Sponsors, Influencers & Career Engineering for Legal Counsel
Women, Diversity & Change Summit - Washington, D.C.
Online
Speaker
May
2
2019
4th Annual Mintz /ML Strategies Pharmacy & Pharmaceutical Industry Summit
Mintz and ML Strategies
Boston, MA
Moderator
May
8
2018
3rd Annual Mintz /ML Strategies Pharmacy & Pharmaceutical Industry Summit
Mintz and ML Strategies
Boston, MA
Panelist
Moderator
Speaker
Speaker
Nov
12
2015
4th Annual Pharmacy Benefit Oversight & Compliance Conference
CBI
16770 North Perimeter Drive Scottsdale, AZ
Speaker
Read less
